Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
3(30%)
Results Posted
17%(1 trials)

Phase Distribution

Ph not_applicable
5
50%
Ph phase_2
1
10%
Ph phase_4
2
20%
Ph phase_1
1
10%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(6)
Terminated(1)

Detailed Status

Completed6
Active, not recruiting2
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 21 (11.1%)
Phase 42 (22.2%)
N/A5 (55.6%)

Trials by Status

recruiting110%
active_not_recruiting220%
completed660%
withdrawn110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10